Q04206 (TF65_HUMAN) Homo sapiens (Human)

Transcription factor p65 UniProtKBInterProSTRINGInteractive Modelling

551 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; ) Identical sequences: Gorilla gorilla gorilla: G3SHV6

Sequence Features

Add
 246-549Missing (found in a patient diagnosed with autoimmune lymphoproliferative syndrome; unknown pathological significance) VAR_081858
 21-186Rel homology domain (RHD), DNA-binding domain
IPR011539PF00554
 195-291Rel homology dimerisation domain
IPR032397PF16179

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
I-KAPPA-B-ALPHA/NF-KAPPA-B COMPLEX Heteromer
P19838; P25963;
1nfi20-314
Assess
Crystal Structure of NFkB, IRF7, IRF3 bound to the interferon-b enhancer Heteromer
P19838; Q14653; Q92985;
2o6120-291
Assess
Crystal structure of a higher-order complex of p50:RelA bound to the HIV-1 LTR Heteromer
P19838;
3gut20-291
Assess
NMR structure of the complex between the KIX domain of CBP and the transactivation domain 1 of p65 Heteromer
P45481;
5u4k521-551
Assess
NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the transacti… Heteromer
P32776;
5urn521-551
Assess
solution structures of BRD4 second bromodomain with NF-kB-K310ac peptide Heteromer
O60885;
2lsp304-316
Assess
14-3-3 sigma with RelA/p65 binding site pS45 in complex with DP005 Heteromer
P31947;
CL;0V4;6nv242-50
Assess
14-3-3 sigma with RelA/p65 binding site pS45 Heteromer
P31947;
GOL;6qhl43-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521 Heteromer
P31947;
L3Y;6yow43-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-123 Heteromer
P31947;
P7E;6ypy43-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-037 Heteromer
P31947;
CL;P6H;6ypl43-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-028 Heteromer
P31947;
CL;P5Q;6yp343-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-025 Heteromer
P31947;
CL;L3S;6yoy43-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-033 Heteromer
P31947;
CL;P6Z;6yp843-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-011 Heteromer
P31947;
CL;P5N;6yp243-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-027 Heteromer
P31947;
CL;L3V;CA;MG;6yox43-51
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-129 Heteromer
P31947;
P7T;6yq243-50
Assess
Crystal Structure of Brd4 Bromodomain 1 in Complex with Acetylated Rel Peptide Heteromer
O60885;
4kv1308-314
Assess
Human SETD6 in complex with RelA Lys310 peptide Heteromer
Q8TBK2;
10×EDO;SAM;3rc0307-312
Assess
Brd4 Bromodomain 2 in Complex with Acetylated Rel Peptide Heteromer
O60885;
DTT;4kv4308-312
Assess
14-3-3 sigma with RelA/p65 binding site pS281 Heteromer
P31947;
6qhm280-282
Assess
Human SETD6 in complex with RelA Lys310 Heteromer
Q8TBK2;
SAM; 11×EDO;3qxy310-310
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
monomer -0.26 2i9t.1.C19-291
97.44
Assess
monomer 0.01 1ooa.1.B18-291
45.64
Assess
monomer -2.59 2lww.1.B427-491
81.54
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 2monomer-0.472i9t.1.C6-278
95.60
Assess
Isoform 2monomer-0.011ooa.1.B6-278
44.76
Assess
Isoform 2monomer-2.011nfi.1.A7-300
98.00
Assess
Isoform 2monomer-2.845urn.1.B515-537
100.00
Assess
Isoform 2monomer-2.592lww.1.B414-478
81.54
Assess
Isoform 3monomer-0.882i9t.1.C19-281
97.34
Assess
Isoform 3monomer-0.101ooa.1.B18-281
45.85
Assess
Isoform 3monomer-1.961nfi.1.A20-303
99.66
Assess
Isoform 3monomer-2.845urn.1.B519-541
100.00
Assess
Isoform 3monomer-2.592lww.1.B417-481
81.54
Assess
Isoform 4monomer-0.112i9t.1.C19-288
97.41
Assess
Isoform 4monomer-1.961nfi.1.A20-310
98.99
Assess
Isoform 4monomer-2.845urn.1.B526-548
100.00
Assess
Isoform 4monomer-2.592lww.1.B424-488
81.54
Assess